3609 studies found for:    "Depressive Disorder" [DISEASE]
Show Display Options
Rank Status Study
21 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
22 Terminated Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Conditions: Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:
23 Completed Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
24 Recruiting Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD)
Conditions: Treatment Resistant Depression;   Depressive Disorder, Treatment-Resistant;   Depression, Bipolar
Intervention: Device: SCC DBS
25 Completed
Has Results
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
Conditions: Depression;   Major Depressive Disorder;   Unipolar Depression
Interventions: Drug: Wellbutrin;   Drug: Placebo
26 Completed Buprenorphine for Treatment Resistant Depression
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Buprenorphine;   Drug: Placebo
27 Active, not recruiting Insulin Resistance in Patients With Major Depression
Conditions: Depression;   Bipolar Disorder;   Mood Disorders;   Insulin Resistance;   Depressive Disorder, Major;   Depressive Disorder
Intervention:
28 Terminated Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder
Interventions: Device: Cortical Stimulation;   Device: Sham
29 Recruiting Deep Brain Stimulation in Patients With Chronic Treatment Resistant Depression
Conditions: Major Depressive Disorder;   Recurrent Depressive Disorder;   Bipolar Disorder
Interventions: Device: DBS;   Device: SHAM
30 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine succinate sustained-release (DVS SR);   Drug: Escitalopram
31 Unknown  Using Neuroimaging to Investigate Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression;   Anxiety
Intervention:
32 Not yet recruiting Study to Treat Major Depressive Disorder (MDD) With a New Medication
Conditions: Major Depressive Disorder;   Depression
Intervention: Drug: ezogabine
33 Withdrawn Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Biological: RO4995819
34 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
Conditions: Depression;   Depressive Disorder;   Depressive Disorder, Major
Interventions: Drug: Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR);   Drug: Placebo
35 Completed Depression Study In Elderly Patients
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: Paroxetine CR
36 Completed
Has Results
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
37 Completed
Has Results
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
38 Completed
Has Results
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder;   MDD;   Depression
Interventions: Drug: TC-5214;   Drug: Placebo
39 Recruiting Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in Remission
Conditions: Repetitive Negative Thinking;   Generalized Anxiety Disorder;   Mild or Moderate Depressive Disorder;   Depression in Remission.
Interventions: Behavioral: Drop It training session;   Behavioral: treatment as usual
40 Completed
Has Results
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
Conditions: Depression;   Major Depressive Disorder
Intervention: Drug: Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years